erlotinib hydrochloride has been researched along with Deficiency, Magnesium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altundag, K; Altundag, O; Atik, MA; Baptista, MZ; Turen, S | 1 |
1 other study(ies) available for erlotinib hydrochloride and Deficiency, Magnesium
| Article | Year |
|---|---|
Re: Cetuximab therapy and symptomatic hypomagnesemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Magnesium; Magnesium Deficiency; Protein-Tyrosine Kinases; Quinazolines | 2005 |